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Abstract
Background: Although the gene expression profile of several tissues in humans and in rodent animal models has
been explored, analysis of the complete choroid plexus (CP) transcriptome is still lacking. A better characterization
of the CP transcriptome can provide key insights into its functions as one of the barriers that separate the brain
from the periphery and in the production of cerebrospinal fluid.
Methods: This work extends further what is known about the mouse CP transcriptome through a microarray
analysis of CP tissue from normal mice under physiological conditions.
Results: We found that the genes most highly expressed are those implicated in energy metabolism (oxidative
phosphorylation, glycolysis/gluconeogenesis) and in ribosomal function, which is in agreement with the secretory
nature of the CP. On the other hand, genes encoding for immune mediators are among those with lower
expression in basal conditions. In addition, we found genes known to be relevant during brain development, and
not previously identified to be expressed in the CP, including those encoding for various axonal guidance and
angiogenesis molecules and for growth factors. Some of these are known to influence the neural stem cell niche
in the subventricular zone, highlighting the involvement of the CP as a likely modulator of neurogenesis.
Interestingly, our observations confirm that the CP transcriptome is unique, displaying low homology with that of
other tissues. Of note, we describe here that the closest similarity is with the transcriptome of the endothelial cells
of the blood-brain barrier.
Conclusions: Based on the data presented here, it will now be possible to further explore the function of
particular proteins of the CP secretome in health and in disease.
Background
The choroid plexus (CP) is located in the ventricles of
the vertebrate brain. It is formed by a monolayer of
epithelial cells that surrounds a central stroma in which
fenestrated blood vessels are embedded in a rich extra-
cellular matrix. In addition, and depending on the phy-
siological or pathological conditions, the stroma also
contains cells such as fibroblasts, macrophages, neutro-
phils, dendritic cells, plus B and T cells. Tight junctions
between the apical sides of the epithelial cells separate
the blood from the cerebrospinal fluid (CSF); this pro-
vides the barrier function that normally hinders the free
movement of molecules and cells from the blood into
the CSF. It is well recognized that the CP’s principal
function is the production of CSF [1]. However, it is
also known that the CP participates in other key func-
tions, namely the transport of nutrients into the brain
and the removal of metabolic products out of the brain
[2]. This seems to be of relevance in diseases such as
Alzheimer’s, where CP proteins in the apical membrane
participate in the clearance of the amyloid beta peptide,
alone or bound to CSF carrier proteins [3-5]. In addi-
tion, the CP is able to respond to challenges by display-
ing additional functions not present under basal
conditions. It has been recently shown that the CP spe-
cifically responds differently to peripheral inflammation,
depending on whether the inflammation is acute or sus-
tained, by secreting several immuno modulators [6-9].
Moreover, in conditions of inflammation, the CP seems
to be important in the regulation of brain iron
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homeostasis [10,11]. The CP is also one of the first
places of entry for the immune cells during neurological
disorders, as shown in the experimental autoimmune
encephalomyelitis model of multiple sclerosis [12].
Although a vast number of CP mRNA/proteins have
been previously described in the literature, discussion of
the full basal transcriptome is still lacking. The data
herein presented supports the view that the CP is more
than a barrier that restricts the passage of molecules
and cells in and out of the brain, but rather a tissue that
should be better studied as an active participant in brain
homeostasis in both physiological and pathological
conditions.
Methods
All experiments and procedures followed the European
Community Council Directive 86/09/EEC guidelines for
the care and handling of laboratory animals and were
approved by the Life and Health Sciences Research
Institute’s ethical committee and by the Portuguese
Veterinary Authorities ("Direcção Geral de Veterinária”
process reference number 520/000/000/2006).
Animals
All experiments were conducted using 8- to 9-week
old C57BL/6 male mice (Charles River, Barcelona, Spain).
Animals were maintained under 12 h light/dark cycles at
22.5°C and 55% humidity and fed with regular rodent
chow and tap water ad libitum. In order to reduce the
stress-induced changes in the hypothalamus-pituitary axis,
animals were handled for 1 week prior to the start of the
experiment. Mice were anesthetized with intraperitoneal
injection of ketamine hydrochloride (150 mg/Kg) plus
medetomidine (0.3 mg/Kg) and transcardially perfused
with cold saline. The CPs were rapidly removed, stored in
RNA later (Ambion, Austin, TX, USA) and kept at -80°C.
CP isolation was made under conventional light micro-
scopy (SZX7, Olympus, Hamburg, Germany). Three pools
of CP (each containing tissue removed from the 4 ventri-
cles of 3 mice) were prepared at the time of sacrifice.
While most of the cells are CP epithelial cells, the tissue
sampled may also contain stroma cells (e.g. endothelial
cells and pericytes). These animals correspond to those
used as controls (basal transcriptome) in Marques et al. [8].
Microarray experimental design and data analysis
Total RNA was isolated with Trizol (Invitrogen, Carlsbad,
CA, USA) following manufacturer’s instructions. After
quality assessment using the Agilent Bioanalyzer (Agilent
Technologies, CA, USA), 100 ng of total RNA from each
pool was amplified and labelled with Illumina TotalPrep
RNA Amplification Kit (Illumina Inc., San Diego, CA,
USA). The labelled cRNA was then hybridized in a total
of two Illumina Whole-genome Mouseref-8 expression
Beadchips (Illumina Inc.), following the recommended
protocol, each containing 8 arrays, comprising a total of
24,049 well-annotated RefSeq transcripts per beadchip.
After scanning, raw data from BeadStudio software (Illu-
mina Inc.) was read into R/Bioconductor and normalized
using quantile normalization. A linear model was applied
to the normalized data using Limma package in R/Biocon-
ductor [13]. A contrast analysis was applied and differen-
tially expressed genes were selected using a Bayesian
approach with a false discovery rate of 5%. All data is
Minimum Information About a Microarray Experiment
(MIAME)-compliant and the raw data has been deposited
in the GEO database (accession: GSE23714). In order to
analyze and compare the CP transcriptome with transcrip-
tomes from other tissues, the initial list containing the
24,049 CP genes was filtered: the repeated genes present
in the array platform were excluded and the genes with a
Coefficient of Variation (CV) ≥ 30 across the 3 replicates
were also removed. The final gene list included 18,160
genes. For the analysis, normalized genes were categorized
using the Gene Set Analysis Toolkit from WebGestalt
(http://bioinfo.vanderbilt.edu/webgestalt/ [14]) or the
Ingenuity tools (Redwood City, CA, USA). Enrichment
analysis was performed using DAVID (http://david.abcc.
ncifcrf.gov/ [15]) and Ingenuity (http://www.ingenuity.com
[16]) software. For comparison with other transcriptomes,
two studies of the GEO database were used: one contain-
ing 61 mouse different tissues in physiological conditions
(GDS592) [17], and another containing the transcriptome
of the PECAM-1+ blood-brain barrier (BBB) microvascu-
lar endothelial cells (ppMBMECs) (GSE14375) [18]. From
each gene list the repeated genes and the genes with CV ≥
30 were removed. After these corrections, a list containing
the genes common in the three studies was created, ana-
lyzed with the Limma package to normalize data between
arrays and, subsequently, a cluster was constructed using
the Multiexperiment Viewer program.
The GEO database has data on two other CP studies.
One focuses on the differential CP expression between
B10.pl WT and B10.PL RAG-/- mice (GSE11443); the
other evaluates the gene expression profile of 24 neural
tissues (including the CP from the 4th ventricle) and 10
other body tissues/organs (GSE3594). We compared our
transcriptome with the control transcriptome of each of
these two other studies. For these comparisons, we
selected the common genes excluding those presenting
a CV ≥ 30. After these corrections, data between arrays
was normalized with the Limma package, followed by a
comparison of the expression level for each gene.
Confirmation of the array data by RT-qPCR
In order to validate the array data, 20 genes within the
lower range of expression (6.1-7.0) were analyzed in an
independent set of CP samples. The selected genes
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were: inducible T-cell co-stimulator, myotubularin-
related protein 7, retinal pigment epithelium 65, dual
oxidase 2, arginine vasopressin receptor 1B, glutathione
peroxidase 5, nestin, epithelial mitogen, interleukin 6,
neuropeptide Y, matrix metalloproteinase 9, glucagon
receptor, claudin 15, ceruloplasmin, lipocalin 2, CD14
antigen, vav 1 oncogene, retinoic acid receptor gamma,
interferon regulatory factor 1 and toll-like receptor 4.
Gene abbreviations and gene names are specified in
accordance with the HUGO Gene Nomenclature Com-
mittee at http://www.genenames.org/ [19]. Total RNA
was isolated from five pools of CP using Trizol reagent
(Invitrogen), and 500 ng amplified using the Superscript
RNA amplification system (Invitrogen) according to the
manufacturer’s instructions. CP RNA was reverse tran-
scribed using random primers of the Superscript First-
strand Synthesis system for RT-PCR (Invitrogen).
The oligonucleotide primers (sequences available upon
request) were designed using the Primer3 software on
the basis of the GenBank sequences. Real-time PCR
reactions, using equal amounts of total RNA from each
sample, were performed on a CFX 96™ real-time sys-
tem instrument (Bio-Rad Laboratories, Hercules, CA,
USA) using QuantiTect SYBR Green RT-PCR reagent
kit (Qiagen, Hamburg, Germany). Product fluorescence
was detected at the end of the elongation cycle. All
melting curves exhibited a single sharp peak at a tem-
perature characteristic of the primers used.
Construction of biological function networks
In order to identify major functions of the CP, networks
based on the genes displaying higher expression (thresh-
old 13 in the array) were constructed. Analysis yielded
59 genes that were subsequently analysed in the FunNet
(http://www.funnet.info [20]) for GO Molecular Func-
tion and Kyoto Encyclopedia of Genes and Genomes
(KEGG) functional networks. This program clusters the
genes depending on their biological function, creating
nodes corresponding to those that are most enriched.
The relation between every pair of genes is calculated
using the signal expression of the genes on the corre-
sponding biological functions.
Results
CP transcriptome characterization
From the complete array analysis, we found that the
majority of genes in the CP transcriptome are expressed
at very low levels. From a range of expression levels that
varied from 6.1-15.0, (log2-transformed absolute expres-
sion levels), 81% of the genes were expressed between
the 6.1-8.3 level; 15% were expressed at levels between
8.3-10.5; 4% were expressed with the level between 10.5-
12.8 and only 0.4% of the genes were highly expressed
and presented an expression level between 12.8-15.0
(Figure 1). All the genes detected and their relative
expression levels are presented as Additional File 1
(Expression levels of the genes transcribed in the basal
choroid plexus) and deposited in the GEO database
GSE23714.
Twenty genes, with expression levels ranging from 6.1
to 7.0, were further analyzed by RT-qPCR in CP col-
lected from an independent group of animals. This ana-
lysis confirmed the relative expression of these genes
(data not shown), and indicated that genes with an
expression level of 6.1, the lowest level in the array, are
detectable by RT-qPCR. Altogether, it was inferred from
the analysis that the array data represented genes
expressed under basal physiological conditions.
Table 1 lists the fifty-nine most highly expressed genes
(threshold 13.0 in the array). Analysis of the genes dis-
playing expression levels above 13 were clustered in par-
ticular functional networks (Figure 2). Analysis of gene
function networks identified 3 modules of interaction
for the 59 mostly expressed genes. One included genes
participating in pathways such as regulation of the tissue
remodelling, fibril organization, negative regulation of
processes such as extracellular matrix disassembly and
blood vessel remodelling. Another, included genes of
iron homeostasis, carbohydrate and lipid metabolism.
A third module included genes involved in free radical
homeostasis, regulation of the inflammatory response,
mitochondrial metabolism and RNA processing. A table
containing the various genes in each module is provided
as Additional File 2 (Functional networks of the most
highly-expressed genes in the choroid plexus).
Figure 3 identifies the molecular pathways encompassing
genes with an expression level between 6.1-12.8. Of
Figure 1 Frequency graph showing choroid plexus gene
expression profile. From the 18,160 analyzed genes, approximately
81% of the genes presented with expression levels between 6.1 and
8.3; 15% were expressed at levels between 8.3-10.5; 4% were
expressed with the level between 10.5-12.8 and only 0.4% of the
genes were highly expressed by the CP and presented with an
expression level between 12.8-15.0.
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Table 1 Most highly expressed genes found in the choroid plexus in normal physiological conditions
Symbol Definition E.value
Ubb ubiquitin B 15.0
Igf2 insulin-like growth factor 2 14.6
Rpl41 ribosomal protein L41 14.5
Cox4i1 cytochrome c oxidase subunit IV isoform 1 14.1
Clu clusterin 14.1
Psap prosaposin 14.0
Chchd10 coiled-coil-helix-coiled-coil-helix domain containing 10 14.0
Arl6ip1 ADP-ribosylation factor-like 6 interacting protein 1 13.9
Atp5b ATP synthase, H+ transporting mitochondrial F1 complex. beta subunit 13.9
Cst3 cystatin C 13.9
Clic6 chloride intracellular channel 6 13.8
Ttr transthyretin 13.8
1500015O10Rik RIKEN cDNA 1500015O10 gene 13.7
Grim19 genes associated with retinoid-IFN-induced mortality 19 13.7
Cox8a cytochrome c oxidase, subunit VIIIa 13.7
Gapd glyceraldehyde-3-phosphate dehydrogenase 13.7
Atp5h ATP synthase. H+ transporting, mitochondrial F0 complex. subunit d 13.7
Uba52 ubiquitin A-52 residue ribosomal protein fusion product 1 13.6
Uqcrh ubiquinol-cytochrome c reductase hinge protein 13.6
Ckb creatine kinase. brain 13.6
Cox6a1 cytochrome c oxidase. subunit VI a, polypeptide 1 13.6
Gpx4 glutathione peroxidase 4 13.6
Rps14 ribosomal protein S14 13.6
Ppia peptidylprolyl isomerase A 13.6
Rplp1 ribosomal protein. large, P1 13.6
Aldh2 aldehyde dehydrogenase 2, mitochondrial 13.6
Rnaset2 ribonuclease T2 13.5
Rps27a ribosomal protein S27a 13.5
Rps29 ribosomal protein S29 13.5
Dbi diazepam binding inhibitor 13.5
Atp5j2 ATP synthase, H+ transporting. mitochondrial F0 complex, subunit f. isoform 2 13.5
Grina glutamate receptor, ionotropic. N-methyl D-asparate-associated protein 1 (glutamate binding) 13.5
1110020P15Rik RIKEN cDNA 1110020P15 gene 13.5
Atp1a1 ATPase, Na+/K+ transporting. alpha 1 polypeptide 13.5
Fth1 ferritin heavy chain 1 13.4
Ptgds prostaglandin D2 synthase (brain) 13.4
Atp5g3 ATP synthase. H+ transporting, mitochondrial F0 complex. subunit c (subunit 9), isoform 3 13.4
Cd81 Cd81 antigen 13.4
Ndufa1 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex. 1 13.3
Atp1b1 ATPase. Na+/K+ transporting, beta 1 polypeptide 13.2
Cd63 Cd63 antigen 13.2
Cox5b cytochrome c oxidase. subunit Vb 13.2
Ubc ubiquitin C 13.2
Sostdc1 sclerostin domain containing 1 13.2
Rps20 ribosomal protein S20 13.2
Ubl5 ubiquitin-like 5 13.1
Aplp2 amyloid beta (A4) precursor-like protein 2 13.1
Scd2 stearoyl-Coenzyme A desaturase 2 13.1
Rbp1 retinol binding protein 1. cellular 13.1
Ndufa4 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 13.1
Rpl3 ribosomal protein L3 13.1
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Figure 2 Functional and network analysis of the most highly-expressed genes. Analysis of the genes displaying expression levels above 13
clustered in particular functional networks. Different shapes represent different modules of biological functions. Dashed lines are relationships
between nodes in different modules and solid lines are relationships between nodes in the same module. Dashed lines depict medium strong
interactions (i.e. in between the median of the distribution and its upper quartile) and solid lines indicate the strongest interactions (i.e. superior
to the upper quartile of their distribution). The interactional centrality of GO themes is illustrated by the size of the corresponding nodes. A red
line denotes that the same gene is linked between all the biological process and gray lines denote different genes in each node.
Table 1 Most highly expressed genes found in the choroid plexus in normal physiological conditions (Continued)
2010107E04Rik RIKEN cDNA 2010107E04 gene 13.1
Cryab crystallin, alpha B 13.0
Vdac1 voltage-dependent anion channel 1 13.0
Car12 carbonic anyhydrase 12 13.0
Rpl35 ribosomal protein L35 13.0
Cox7c cytochrome c oxidase. subunit VIIc 13.0
Rps21 ribosomal protein S21 13.0
Ldh2 lactate dehydrogenase 2, B chain 13.0
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note, is the number of genes clustered in classes related
to oxidative phosphorylation and ribosomal function,
which is in agreement with the high secretory capacity
of the CP. Interestingly, adhesion and regulation of actin
cytoskeleton are also highly expressed, probably reflect-
ing the barrier functions. In addition, it highlights genes
belonging to various signalling pathways.
Classes of genes expressed in the CP and their functions
The CP has traditionally been viewed as a tissue that
provides the brain with secreted CSF, which through
bulk flow, supplies the brain with some nutrients such
as vitamin C, amino acids, nucleosides and transport
proteins such as transthyretin. The CP is also known to
facilitate the removal of products of brain metabolism
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such as free iodine, glutamate and amyloid beta peptide.
On the other hand, the CP provides a barrier that
restricts the passage of molecules and cells into and out
of the brain. The present study provides solid evidence
to support this view. In agreement we found that the
CP transcriptome includes genes encoding for the tight
junctions proteins (Figure 4A), for transporters namely
for monocarboxylic acid (Slc16a9), glucose (Slc2a1),
vitamin C (Slc23a2), thiamine (Slc19a2), zinc (such as
Slc39a1) (Figure 4B) and for receptors of various classes
of neurotransmitters such as dopamine, serotonin,
opioids, cannabinoids, glutamate, histamine and GABA
and also receptors for folate, benzodiazepine, estrogen
and growth hormone (Figure 4C). Of notice, with
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respect to transporters, the CP highly expressed both
the ABC (all 7 distinct sub-families: ABC1, MDR/TAP,
MRP, ALD, OABP, GCN20, White) and the Slc families
(Figure 4B). In addition to the MDR/TAP and MRP, the
basal transcriptome also revealed the presence of the
solute carrier organic anion families (OAT and OATP)
of efflux transporters. Finally, the sodium-dependent
system for the excitatory acidic amino acids, e.g., gluta-
mate and aspartate, was also expressed in the CP and
suggests a mechanism for net removal of potentially
neurotoxic amino acids from the brain. The CP also
expressed different genes that encode transporters for
glucose, fatty acid, monocarboxylic acid, nucleoside, gly-
cerol, cationic amino acid transporter y+ system, iodide
and neurotransmitter transporters (Figure 4B).
We chose to further highlight genes encoding for axo-
nal guidance (Figure 5A), and for growth factors (Figure
5B) given their relevance for brain development and
also for adult neurogenesis, as will be discussed later.
These include insulin-like growth factor 2, transforming
growth factor beta 2, vascular endothelial growth factor
A and B, brain derived neurotrophic factor, ciliary neu-
rotrophic factor transcript variant 2, fibroblast growth
factors, betacellulin epidermal growth factor family
member and its receptor ErbB-4, neuregulin 1, 3 and 4,
amphiregulin, epiregulin and several members of the
Wnt family (Additional File 1). With respect to axonal
guidance, the CP basal transcriptome includes the four
conserved families of guidance cues shown to have pro-
minent developmental effects: netrins, semaphorins,
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SLIT and ephrins, as well as their respective receptors.
Not surprisingly, among the most highly expressed
genes are those encoding for major CSF proteins, such
as transthyretin, prostaglandin D2 synthase, transferrin,
insulin-like growth factor 2, clusterin (apolipoprotein J)
and cystatin C (Table 1).
CP transcriptome comparison with other mouse tissue
transcriptomes
From the 62 tissues analysed, the CP transcriptome cor-
related with the transcriptome of the BBB endothelial
cells more closely than with tissues from other brain
regions or other peripheral tissues (data not shown).
We compared our CP array data with two others that
are deposited in the GEO database, the GSE11443 and
GSE3594. We observed that the correlation between our
CP data was approximately 56% when compared to
GSE11443 and 57% when compared to GSE3594. To test
if the correlation we found between our study and the two
others was acceptable, we also compared the correlation
between the two other studies and found a correlation of
63%. Interestingly a similar correlation was found when
the liver transcriptome from different studies was com-
pared, which in this case had a correlation of 53%. Since
the mostly expressed genes are those that best characterize
a tissue, we also analysed if the fifty most highly-expressed
genes in our study corresponded to the same fifty most
highly-expressed genes in the two other CP studies. We
observed that 34 and 20, from the GSE11443 and
GSE3594 respectively, are common between the studies.
Among the mostly expressed genes in these 3 studies are
the genes encoding for Arl6ip1, Ckb, Cox6a1, Cst3, Igf2,
Ptgds, Rbp1, Rpl41, Slc4a2, Ttr and Ubc.
Discussion
Here we analysed and characterized the mouse CP tran-
scriptome under normal basal physiological conditions.
Unravelling the transcriptome signature of a tissue is a
valuable tool for better understanding its functions in
health and in disease. In this particular case, as part of
the barriers that separate the brain from the periphery,
it has become clear that the CP is more than an obstacle
for molecule and cell trafficking into and out of the
brain; it is an active participant in brain homeostasis.
Not surprisingly, we confirmed that among the genes
most highly expressed were those encoding for proteins
that are secreted into the CSF, such as transthyretin and
transferrin. These are carriers for the ligands thyroxine
and iron respectively, which are relevant for proper brain
function during development and throughout adulthood.
While CP transthyretin in itself does not seem essential
for thyroid hormone to reach and distribute within the
brain parenchyma [21], the available data does not exclude
a role for the CP in thyroid hormone homeostasis. In fact,
the thyroid gland is the sole site recognized for thyroid
hormone synthesis. However, when the thyroid gland is
ablated, it takes several months for the tissues to be
depleted of thyroid hormones [22,23], which raises the
possibility of extrathyroidal sites for thyroid hormone
synthesis. The CP could be such a place, not only because
it expresses the sodium-iodine symporter [24], which
uptakes iodine against a concentration gradient, but also
several peroxidases (glutathione peroxidase 4, 1, 3, 7, mye-
loperoxidase, thyroid peroxidase) as we now show in this
study. Future investigation should address whether these
peroxidases have the same ability as thyroid peroxidase in
the thyroid to oxidise iodine and incorporate it into thyro-
globulin (also present in the basal CP transcriptome) or
other tyrosine containing protein.
Analysis of the basal transcriptome revealed genes
involved in iron homeostasis such as transferrin; how-
ever, it is notable that participation in brain iron home-
ostasis seems to be particularly relevant in response to
stimuli such as peripheral inflammation [11]. These
observations highlight the ability of the CP to respond/
adapt to physiological and disease states.
Several genes were shown to be expressed in the CP
for the first time. These include those encoding for the
opioid receptors, for which we found mRNA for all
members of the family, the opioid receptor sigma 1
being the most highly expressed. Other studies, using
autoradiographic techniques with selective ligands, failed
to detect the mu and delta opioid receptors in rat CP
brain [25,26], probably due to the lower sensitivity of
the methodologies used. The present study also con-
firmed the presence of other neurotransmitter receptors
previously described in the CP [27], such as the dopa-
mine receptors. Again, this emphasizes an active role of
the CP as a potential site for modulating response to
neurotransmitters, which should be further investigated
in the context of mood disorders.
We consider it of interest that the adult CP expresses
genes encoding for several growth factors and axonal
guidance molecules. While semaphorin 3f [2] and Slits 2
and 3 [28,29] were previously described in the develop-
ing CP, we described here for the first time the expres-
sion of various netrins and ephrins. The present study
also adds to previously described growth and trophic
factors [30,31], such as insulin-like growth factor II [32],
glial cell line-derived neurotrophic factor [33], trans-
forming growth factor alpha [34], fibroblast growth fac-
tor 2 [35] and vascular endothelial growth factor [36].
The expression of genes encoding for several members
of the FGF family (those with higher expression value
being FGF 18, 9 and 3), neuregulin, betacellulin and
epiregulin should be highlighted. Betacellulin and its
receptor ErbB-4 are highly expressed in neurons, imply-
ing important roles in neuronal cell functions; and
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inducing ErbB-4 activation promotes neurite outgrowth
in PC12 cells [37]. Numerous genetic modelling studies
in mice demonstrate that neuregulin 1 signalling is
important in the development of normal neuronal con-
nectivity. Of particular interest to this discussion are
findings linking deficits in neuregulin 1-ErbB4 signalling
to perturbations of synaptic transmission, myelination,
and the survival of particular sets of neurons and glia
[38]. It will be of interest to next investigate the partici-
pation of the CP in demyelinating diseases.
The CP expression of growth factors is also relevant in
the context of neurogenesis. The subventricular zone is,
together with the hippocampus, a site of adult neuro-
genesis. We showed here that the genes encoding for
molecules that modulate adult neural stem cell prolif-
eration and fate are transcribed in the CP. It is surpris-
ing that few studies so far have considered the CP as a
relevant source of such mediators. The present study
draws attention to the CP, as a modulator of the CSF
composition, in the distribution of key molecules for
neuronal differentiation.
Finally, the data we presented here confirms that the
CP transcriptome displays a specific signature, different
from all other tissues for which transcriptome data is
available [39]. While one could anticipate resemblance
with other secretory epithelia, such as the lung, the clo-
sest similarity is with that of the PECAM-1+ BBB micro-
vascular endothelial cells [18]. This most likely reflects
the fact that both have a barrier function, mediated by
tight junctions; participate in the transport of molecules
in and out of the brain, through several transporters and
receptors; and in detoxifying processes, through several
enzymes [31,40]. Despite these similarities, there are
striking differences in gene expression between these two
barriers, such as is the case for carbonic anhydrase 12,
which is involved in CSF production (13.0 versus 4.4).
Conclusions
In summary, the present work reveals that the CP is a
site of active expression of several molecular pathways
of relevance for brain homeostasis. Understanding its
involvement in various physiological and disease states
may provide novel clues to disease mechanisms, and
also unravel novel targets for therapies against diseases
of the central nervous system.
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